ProFrac (NASDAQ: ACDC) CCO receives 41,790 performance-based stock awards

Rhea-AI Filing Summary

Greenwood Matthew A reported acquisition or exercise transactions in this Form 4 filing.

ProFrac Holding Corp. Chief Commercial Officer Matthew A. Greenwood reported an equity award of 41,790 shares of Class A common stock. The shares were issued at no cash cost as part of performance share awards tied to EBITDA, free cash flow and other performance criteria for the 2025 performance period.

Performance-vesting restrictions on these shares were released after the Compensation Committee certified that the performance goals were attained. Following this award, Greenwood directly holds 184,607 shares. The March 2025 performance grant is scheduled to vest in equal portions on March 28, 2026, 2027 and 2028, while the March 2023 grant will vest on March 31, 2026, subject to continued service and good standing.

Insider Trade Summary

Net Buyer: 41,790 shares

Net Buy 1 txn

Insider Greenwood Matthew A

Role Chief Commercial Officer

Type	Security	Shares	Price	Value
Grant/Award	Class A common stock, par value $0.01 per share	41,790	$0.00	$0.00

Holdings After Transaction: Class A common stock, par value $0.01 per share — 184,607 shares (Direct)

Footnotes (1)

1. F1. Represents 34,743 and 7,047 shares of Company common stock issued under performance share awards granted to the reporting person on March 28, 2025 (the "March 2025 Grant") and March 31, 2023 (the "March 2023 Grant"), respectively. The awards are subject to performance-vesting restrictions based on EBITDA, free cash flow and other performance criteria for the performance period from January 1, 2025 to December 31, 2025. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the Company's Board of Directors. The shares of the March 2025 Grant will vest equally on March 28, 2026, March 28, 2027 and March 28, 2028, subject to the reporting person's continued service and good standing through each applicable vesting date. The shares of the March 2023 Grant will vest on March 31, 2026.

FAQ

What insider transaction did ProFrac (ACDC) report for Matthew A. Greenwood?

ProFrac reported that Chief Commercial Officer Matthew A. Greenwood received 41,790 shares of Class A common stock as an equity award. The shares came from performance share awards that vested after the Compensation Committee certified achievement of EBITDA, free cash flow and other performance goals for the 2025 period.

Was the ProFrac (ACDC) insider transaction a market purchase or sale?

The transaction was a grant or award acquisition, not a market trade. Greenwood received 41,790 shares at a reported price of $0.0000 per share as part of performance share awards, reflecting compensation rather than a discretionary open-market buy or sell.

How many ProFrac (ACDC) shares does Matthew A. Greenwood hold after this Form 4?

After this equity award, Matthew A. Greenwood directly holds 184,607 shares of ProFrac Class A common stock. This total includes the newly released performance shares that vested upon certification of performance goals and continues to represent his ongoing equity stake in the company.

What performance conditions were tied to the ProFrac (ACDC) share awards for Greenwood?

The awards were subject to performance-vesting restrictions based on EBITDA, free cash flow and other performance criteria for the period from January 1, 2025 to December 31, 2025. Vesting occurred after the Compensation Committee certified that these performance goals were achieved for that performance period.

What is the vesting schedule for Matthew A. Greenwood’s ProFrac (ACDC) performance share awards?

Shares from the March 2025 grant will vest in three equal installments on March 28, 2026, March 28, 2027 and March 28, 2028. Shares from the March 2023 grant are scheduled to vest on March 31, 2026, all subject to Greenwood’s continued service and good standing.

Did the ProFrac (ACDC) Form 4 mention any special conditions on Greenwood’s awards?

Yes. The filing states that vesting depends on achievement of EBITDA, free cash flow and other performance criteria, plus Greenwood’s continued service and good standing through each vesting date. Performance restrictions were lifted only after the Compensation Committee certified attainment of the specified performance goals.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 03/11/2026 - 04:15 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Greenwood Matthew A

(Last) (First) (Middle)

C/O PROFRAC HOLDING CORP.

333 SHOPS BOULEVARD, SUITE 301

(Street)

WILLOW PARK TX 76087

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ProFrac Holding Corp. [ ACDC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Commercial Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A common stock, par value $0.01 per share	03/09/2026		A		41,790(1)	A	$0	184,607	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents 34,743 and 7,047 shares of Company common stock issued under performance share awards granted to the reporting person on March 28, 2025 (the "March 2025 Grant") and March 31, 2023 (the "March 2023 Grant"), respectively. The awards are subject to performance-vesting restrictions based on EBITDA, free cash flow and other performance criteria for the performance period from January 1, 2025 to December 31, 2025. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the Company's Board of Directors. The shares of the March 2025 Grant will vest equally on March 28, 2026, March 28, 2027 and March 28, 2028, subject to the reporting person's continued service and good standing through each applicable vesting date. The shares of the March 2023 Grant will vest on March 31, 2026.

	/s/ Steven Scrogham, Attorney-in-Fact	03/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.